VistaGen Therapeutics, Inc.

/VistaGen Therapeutics, Inc.

Follow-on

VistaGen Therapeutics, Inc.

Biopharmaceutical

We are a clinical-stage biopharmaceutical company committed to developing new generation therapies for anxiety, depression and certain additional central nervous system (CNS) disorders for which we believe current treatment options are inadequate, resulting in high unmet need in large and growing markets worldwide.

Symbol

VTGN

Last Closing Price
$0.87

Shares
12,000,000

Anticipated Date
August 3, 2020

Underwriters
MAXIM GROUP LLC

This offering is no longer available

To view the prospectus for VistaGen Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277